Company / Accounts Receivable
LeMaitre Vascular Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$33.6M
FY2025
5-year range
$19.6M / $33.6M
FY2021-FY2025
Trend
+11.8%
vs FY2024
Sector context
#121 of 138
Health Care
What the data says
LeMaitre Vascular's accounts receivable of $34M is lower than 88% of companies in the Health Care sector (FY2025). Accounts Receivable has increased for 9 consecutive years, from $13M in FY2016 to $34M in FY2025.
Based on SEC 10-K filings.
$34M in FY2025 with a 5-year CAGR of +11.4%.
Improved from $25M to $34M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +15.1%
- 5-Year CAGR
- +11.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 138This company $33.6M Sector average $1.3B
▼
-97.5% below sector average
Key checks
Key Insights
- LeMaitre Vascular's accounts receivable has grown for 9 consecutive years.
- 5-year CAGR of +11.4%, indicating consistent growth.
- In FY2025, accounts receivable increased 11.8% year-over-year.
- Ranks #121 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $33.6M | +11.8% |
| FY2024 | $30.1M | +19.9% |
| FY2023 | $25.1M | +13.7% |
| FY2022 | $22.0M | +12.3% |
| FY2021 | $19.6M | +0.4% |
| FY2020 | $19.6M | +18.0% |
| FY2019 | $16.6M | +5.4% |
| FY2018 | $15.7M | +4.8% |
| FY2017 | $15.0M | +13.7% |
| FY2016 | $13.2M | +10.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026